Due to BD's Monday, October 6 announcement that it plans to acquire CareFusion, Life Sciences Segment President Linda Tharby will attend the October 9 Leaders' Club breakfast in place of CEO Vincent Forlenza.
About Linda Tharby:
BD is a leading global medical technology company that services healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 29,000 associates in more than 59 countries throughout the world. The company is dedicated to improving people’s health throughout the world.
Linda Tharby was promoted to Segment President, Life Sciences Segment in October 2014. In this role Linda works closely with both business units, as well as BD’s senior business, functional and regional leadership on corporate and segment strategy, M&A, and company initiatives such as customer-centricity, innovation, operating effectiveness and talent management, while ensuring the acceleration of growth and the delivery of company performance goals. Prior to that, Linda was promoted to Group President, Preanalytical Systems and BD Biosciences in October 2013.
Ms. Tharby started her career at BD in 1996. A global leader in BD, operating at the General Manager level for 13 years, she has served in seven different roles, in five different business units and in two different countries. Her prior roles include sales and marketing leadership roles in Diabetes Care and Medical Surgical, General Manager – BD Canada, VP/GM Pharmaceutical Systems and her most recent role as WW President, Diabetes Care.
Ms. Tharby has successfully developed and led execution of several global business and partnership strategies with a deep focus on innovation, unmet needs and organizational development. In her experience prior to BD, Linda held positions in the consulting, application software and consumer packaged goods industries.
Ms. Tharby is a Canadian citizen, having worked and lived in Canada until 2005. She was honored as 2012 Woman of the Year by the Northern New Jersey and Rockland County Chapter of the Juvenile Diabetes Research Foundation for her extensive work with diabetes care throughout her career. Linda also serves on the Board of Overseers of the Columbia School of Public Health. She graduated from Wilfrid Laurier University in Ontario, Canada with an Honors Bachelor of Business Administration.
About Vincent Forlenza:
As President since January 1, 2009, Mr. Forlenza has overseen BD’s three business segments (BD Medical, BD Diagnostics and BD Biosciences), International and the Quality function. In January 2010, Mr. Forlenza assumed responsibility for the Integrated Supply Chain and Information Technology functions and in July 2010 was named CEO.
Mr. Forlenza joined BD in 1980. His BD career has spanned strategic planning, marketing, general management of several business units and executive leadership. His prior roles include service in all three business segments, including service as General Manager, Hypodermic – Europe; President, Becton Dickinson Microbiology Systems; Senior Vice President, Technology, Strategy and Development; and President, BD Biosciences. He was named Executive Vice President in 2006 and was most recently responsible for leading BD Diagnostics.
Mr. Forlenza obtained his bachelor’s degree in chemical engineering from Lehigh University and his MBA from Wharton Graduate School, University of Pennsylvania. He serves as chairman of The Valley Hospital Board of Trustees and is a member of the Advisory Board for the P.C. Rossin College of Engineering and Applied Sciences at Lehigh University.
Photo: World Economic Forum